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The history of the term Lean is relatively recent and originates from the Toyota Production System (TPS). The term
"Lean" means "thin", which refers to a mental process, operational, productive, no-frills, quick but not hasty,
consequential to the previous event. The Lean process flows seamlessly into the result, eliminates unnecessary
complications to the effect, prevents unnecessary equipment processes. The idea is to 'do more with less', like using
the (few) available resources in the most productive way possible, through the elimination of all types of waste that
inevitably accompanies every stage of a production process. Lean management is primarily a management
philosophy, a system of values and behaviors that goes beyond the mere application of the instrument and that,
once internalized, will form the nucleus of the corporate culture. "Lean Oncology" is a term coined to identify a
methodology of care and treatment to cancer patients, consisting on process simplification, streamlining of the
organizational and routes of drug treatment, detection and elimination of waste. Its main objective is the centrality
of the patient.Why “lean” in oncology?
The term Lean is a synonym of simplicity, as well as effi-
ciency. The same Leonardo Da Vinci believed that “Sim-
plicity” is the highest refinement, and Albert Einstein
stated that it is essential to make things as simple as pos-
sible, but not the easy way.
Equity is a derivation of the principles of social justice
and the State has the duty to ensure the satisfaction of
basic needs to everyone. The task of the community in
pursuing fairness can be understood in terms of egalitar-
ianism, that is intended as the duty of the State to guar-
antee everyone the same opportunities in terms of health
care, in obtaining the minimum standard of health
services.
International development of health technologies keeps
pace with the continuous transformation of society in
terms of appearance of new diseases, increase of patient
education and aging population. This process requires an
evolution of care based on appropriateness and fairness
of the offer. The expansion of health care spending is a
widespread phenomenon in all the institutional and
organizational contexts that characterize the modern* Correspondence: paolo.ascierto@gmail.com
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distribution, and reproduction in any mediumhealth systems. The health services must take into ac-
count limited resources to avoid that health will no
longer be an asset available to all due to cost explosion.
One of the emerging issues in oncology, related to the
wave of optimism that comes from improvements in sev-
eral types of cancer from the high cost of new anticancer
drugs, is the overall assessment of the innovative drug
therapies in oncology and, in particular, their clinical,
economic and ethical, to reconcile on the one hand the
guarantee of a fair and uniform patient access to such
care, and secondly the need to allocate resources accord-
ing to appropriateness criteria, perhaps by providing
forms of co-responsibility with the patient and his family,
and always taking into account the issue of economic
viability and compatibility of evidence-based ethical
choices, even in reference to patients with other diseases.
But the other problem to be solved concernes waste.
Nowadays, nobody makes the necessary distinction be-
tween cost and waste. Medicine is responsible for setting
and achieving its objectives (effectiveness), economics
and health policy to apply its principles (efficiency). The
cooperation of the two sciences is necessary in order to
maximize the collective welfare. Economic efficiency
concerning the combination of factors indicates that best
result (output) can be obtained from the resources
(inputs) available, and refers to the incentives to
minimize costs by individual production units.entral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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eliminate (due to habits, organizational powers, etc..). It
is possible to identify different types of waste such as
pharmacological, organizational and procedural. The
fundamental rule in the management of waste is: "The
reduction of waste increases the capital". Waste can be
further distinguished according to the type of waste in:
Defects (lack of quality), Excessive production (greater
than what required at the time), Transport (unnecessary
travel), Waits (material still waiting to be processed),
Stocks (in general the stock is always a waste), Unneces-
sary operations (which is not value added), the process
itself. Typical examples of waste in Oncology are adverse
reactions to inappropriate premedications, unnecessary
PET and CT, improperly used high-cost drugs, excessive
use of growth factors, inappropriate use of antiemetic
therapy, or "maintenance" without scientific evidence.
Some of these are children of the so-called defensive
medicine such as the duplication or redundancy of diag-
nostic tests not really useful and effective for a certain
disease, or the “Therapeutic Obstinate Chemotherapy” in
the terminal phase just to satisfy the hopes of the family,
when they prefer hearing: "We can do something," rather
than saying “There is nothing we can do”."Lean Oncol-
ogy" is a term coined to identify a methodology of care
and treat cancer patients, consisting on process simplifi-
cation, streamlining of the organizational and routes of
drug treatment, detection and elimination of waste. Its
aim is the wellbeing of the patient, who is the centre of
this process. The history of the term Lean is relatively re-
cent and originates from the Toyota Production System
(TPS). This is the result of a production philosophy that
is closely affected by cultural influences of the environ-
ment in which it arises: Japan. The discipline, the con-
tinuous search for perfection, the care for detail and
research are the most effective background of the culture
of the samurai. In the mid-twentieth century, President
and CEO of Toyota Motor Company introduced innova-
tive principles in the field of production that go under
the name of Lean Manufacturing or Lean Production, a
term coined in 1988. The first time managers around the
world heard of the revolutionary TPS was at the end of
1990, with the book "The Machine That Changed the
World”. The idea is to 'do more with less', i.e. to use the
(few) available resources in the most productive way pos-
sible through the elimination of all types of waste (Muda)
that inevitably accompanies every stage of a production
process. The term "Lean" means "thin",which refers to a
mental process, operational, productive, no-frills, quick
but not hasty, consequential to the previous event. The
Lean process flows seamlessly into the result, eliminates
unnecessary complications to the effect, prevents un-
necessary equipment processes. The primary objective of
the Lean management is the maximization of customervalue and the reduction of resources required to generate
it. In order to achieve this objective, it is necessary to re-
structure the whole process according to 5 basic princi-
ples (value, value stream, continuous flow, pull,
perfection) and then, through the removal of waste and
the spread of the culture of continuous improvement and
problem solving, free the best business resources for re-
use in new strategic challenges, ensuring mutual growth.
The term "Lean" can be applied to any aspect of life (Lean
Thinking, Lean Production, Lean Office, Lean Manage-
ment, Lean Healthcare, etc..). The fundamental principle
of Lean Production is the hunting of waste: anything not
used to increase the value of the product as perceived by
the customer and that the customer is willing to pay is
considered waste and, as such, must be eliminated. In
order to build a lean production it is necessary to iden-
tify the best value stream that leads to the result, team
play action for more actors, standardize routes, improve
standardization and reduce errors. Lean is quick and
simple; if you manage a process with Lean Thinking, you
don’t need to have lots of space to make a smooth pro-
duction process, but it is sufficient that every actor
knows the times and manner of its action (OSS, Nurses
and Doctors).
The world itself is in "Lean" or looks for more and more
regulatory simplification. In Italy the majority of industrial
companies (including health) is currently experiencing a
situation of inadequacy of logic with respect to operational
and organizational dynamics of the market.
The health care companies have realized that the most
careful adjustment goes through a deep revolution of its
structure-oriented simplification and speeding up of op-
erational and management processes. The ideas of Lean
Healthcare and Lean Oncology provide organizational
simplification of access to care, slimming treatments,
waste reduction (avoid non-useful therapies - EBM, high-
cost therapies grouped in the same day), appropriateness
of prescribing medication support, computerization and
reduction of printed media, reduction of errors, appropri-
ateness of admissions, health technology assessment, ap-
propriate use of Target Therapy. The cost-cutting "tout
court" inevitably leads to a reduction of the output in
terms of quality of healthcare received by the patient. For
the “Lean Revolution” there’s the need of a change in
management thinking, based on the collaboration be-
tween economists and health professionals, with an abso-
lute elimination of the personalisms, so that the patient is
the center of the service offered.
Be lean or do lean?
You cannot just "do" Lean: Lean transformation encom-
passes all operational areas of a reality and cannot be
seen as a "project" or a program to reduce costs in the
short term. In this sense, the Lean management is
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and behaviors that go beyond the mere application of
the instrument and that, once internalized, will form
the nucleus of the corporate culture.
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